General Information of the Compound
Compound ID
CP0100241
Compound Name
2-Methyl-10-piperazin-1-yl-4H-3-thia-4,9-diaza-benzo[f]azulene
    Show/Hide
Synonyms
DESMETHYLOLANZAPINE
    Show/Hide
Structure
Formula
C16H18N4S
Molecular Weight
298.415
Canonical SMILES
Cc1cc2c(Nc3ccccc3N=C2N2CCNCC2)s1
    Show/Hide
InChI
InChI=1S/C16H18N4S/c1-11-10-12-15(20-8-6-17-7-9-20)18-13-4-2-3-5-14(13)19-16(12)21-11/h2-5,10,17,19H,6-9H2,1H3
    Show/Hide
InChIKey
FHPIXVHJEIZKJW-UHFFFAOYSA-N
Physicochemical Property
logP
3.09702
Rotatable Bonds
0
Heavy Atom Count
21
Polar Areas
39.66
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 135446209
SID: 14922830
ChEMBL ID
CHEMBL1125
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 14125.38 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 12589.25 nM
Clinical Information about the Compound
Drug 1 ( DESMETHYLOLANZAPINE )
Drug Name DESMETHYLOLANZAPINE
Target(s)
Voltage-gated potassium channel Kv11.1 (KCNH2)
Inhibitor